Warts

Right Decision Service: Dermatology - Viral Warts

Treatment of cutaneous and plantar warts
Salicylic acid + Lactic acid
Salactol paint

Apply daily, treatment may need to be continued for up to 3 months

Salicylic acid
Occlusal 26% solution

Apply daily, treatment may need to be continued for up to 3 months.

Salicylic acid 26% gel

Apply daily, treatment can take several weeks for resistant lesions to disappear and it is necessary to persevere with the treatment.

Prescribing Notes:

  • These preparations are suitable for all cutaneous warts except facial and genital warts.
  • The wart surface should be rubbed with a file or pumice stone, and the surrounding skin protected, before each application. If application becomes painful, treatment should be withheld for a few days then recommenced.
  • Wart removing preparations are keratolytic. They can cause irritation and application to normal or broken skin should be avoided. Surrounding skin to the wart can be protected by applying soft paraffin.
  • Treatment should be continued for at least 3 months and then reviewed.
  • In exceptional circumstances dermatology specialists may recommend formaldehyde 4% solution for plantar warts. For more information see the Primary Care Dermatology Society guidance on warts.
  • Warts may regress on their own and treatment is required only if the warts are painful, unsightly, persistent, or cause distress.

History Notes

12/01/2024

Update to adult pathway title.

08/11/2023

New product addition, Salicylic acid 26% gel, ERWG May 23.

05/10/2022

Discontinued products removed.

15/12/2021

East Region Formulary content agreed.

Treatment of cutaneous and plantar warts

No treatment.

Salicylic acid + Lactic acid
Salactol paint

For dose, refer to BNF for children.

Salicylic acid
Occlusal 26% solution

For dose, refer to BNF for children.

Salicylic acid 26% gel

Refer to product literature.

Prescribing Notes:

  • Treatments are available via pharmacy first. Helpful information for patients can be found on the NHS website.
  • These preparations are suitable for all cutaneous warts except facial or genital warts.
  • The wart surface should be rubbed with a file or pumice stone, and the surrounding skin protected, before each application. If application becomes painful, treatment should be withheld for a few days then recommenced.
  • Wart removing preparations are keratolytic. They can cause irritation and application to normal or broken skin should be avoided. Surrounding skin to the wart can be protected by applying soft paraffin.
  • Treatment should be continued for at least 3 months and then reviewed.
  • In exceptional circumstances dermatology specialists may recommend formaldehyde 4% solution for plantar warts. For more information see the Primary Care Dermatology Society guidance on warts.
  • Warts may regress on their own and treatment is required only if the warts are painful, unsightly, persistent, or cause distress.

History Notes

31/05/2024

East Region Formulary content agreed.

Pharmacy First - Warts and verrucae
Salicylic acid + Lactic acid
Salatac gel

Dose according to age and product licence.

Salactol paint

Dose according to age and product licence.

Salicylic acid
Occlusal 26% solution

Dose according to age and product licence.

Bazuka Extra Strength 26% gel

Dose according to age and product licence.

Prescribing Notes:

  • These preparations are contra-indicated in facial or genital warts.
  • The skin surface should be rubbed with a file or pumice stone and the surrounding skin protected before each application. If application becomes painful treatment should be withheld for a few days, then recommenced.
  • Avoid application to broken skin.
  • Molluscum contagiosum usually resolve spontaneously – refer if concerned.
  • Current practice is to encourage self-care.
  • Helpful information for patients can be found on the NHS website.

Examples of Counselling Points
Treatment may be required for up to 3 months.

When to advise patient to contact GP
Changed appearance of lesions: size, colour.
Bleeding.
Itching.
Genital warts.
Facial warts.
Immunocompromised patients.
Diabetics.
Peripheral Neuropathy.

History Notes

19/12/2024

Bazuka Extra Strength 26% gel added, content agreed ERFC Dec 2024

05/04/2023

Updating 'Salicylic acid 12% / Lactic acid 4% gel' description to 'Salatac gel' to align with Pharmacy First list.

15/12/2021

Added 'Salicylic acid 12% / Lactic acid 4% gel' to align to 01/10/2021 NHS Pharmacy First Scotland - Approved List of Products.

27/10/2020

Content migrated from ‘East Region Formulary: Pharmacy First - supporting minor ailments’ document.